Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Allison

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
Nature Communications|April 28, 2017
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancerJulienne L Carstens, Pedro Correa de Sampaio, Dalu Yang, et al.
Science Translational Medicine|March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapyDmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.
Immunity|July 16, 2011
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokineMoses K Donkor, Abira Sarkar, Peter A Savage, et al.
Cancer Immunology Research|July 1, 2015
Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate CancerKatharina Kreymborg, Stefan Haak, Rajmohan Murali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in miceMeili Zhang, Wei Ju, Zhengsheng Yao, et al.
Nature Communications|August 9, 2016
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapyLewis Zhichang Shi, Tihui Fu, Baoxiang Guan, et al.
Cancer Immunology Research|January 8, 2014
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patientsShigehisa Kitano, Takemasa Tsuji, Caillian Liu, et al.
Journal of Hematology & Oncology|September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case reportMarc Uemura, Van A Trinh, Cara Haymaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signalsJun Mitsui, Hiroyoshi Nishikawa, Daisuke Muraoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2007
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeXingxing Zang, R Houston Thompson, Hikmat A Al-Ahmadie, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
Nature Communications|April 28, 2017
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancerJulienne L Carstens, Pedro Correa de Sampaio, Dalu Yang, et al.
Science Translational Medicine|March 7, 2014
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapyDmitriy Zamarin, Rikke B Holmgaard, Sumit K Subudhi, et al.
Immunity|July 16, 2011
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokineMoses K Donkor, Abira Sarkar, Peter A Savage, et al.
Cancer Immunology Research|July 1, 2015
Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate CancerKatharina Kreymborg, Stefan Haak, Rajmohan Murali, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 18, 2012
Augmented IL-15Rα expression by CD40 activation is critical in synergistic CD8 T cell-mediated antitumor activity of anti-CD40 antibody with IL-15 in TRAMP-C2 tumors in miceMeili Zhang, Wei Ju, Zhengsheng Yao, et al.
Nature Communications|August 9, 2016
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapyLewis Zhichang Shi, Tihui Fu, Baoxiang Guan, et al.
Cancer Immunology Research|January 8, 2014
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patientsShigehisa Kitano, Takemasa Tsuji, Caillian Liu, et al.
Journal of Hematology & Oncology|September 7, 2016
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case reportMarc Uemura, Van A Trinh, Cara Haymaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signalsJun Mitsui, Hiroyoshi Nishikawa, Daisuke Muraoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2007
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcomeXingxing Zang, R Houston Thompson, Hikmat A Al-Ahmadie, et al.
Pageof 21